Integrin alpha V beta 5

Integrin alpha V beta 5

Integrin alpha V beta 5 분자 정보

Molecule Name
Integrin alpha-V/beta-5
분자 별명
Integrin alpha V beta 5,ITGAV&ITGB5
Drug Development Progress
임상 약물 수3
시판 약물 수0
최고 연구 개발 단계Phase 1 Clinical
표적 별명
Receptors, Vitronectin
분자 배경
Integrin alpha V beta 5 (ITGAV & ITGB5) is expressed on a wide variety of cell types including keratinocytes, fibroblasts, adhesive monocytes, embryonic stem cells, and select endothelium and epithelium. ITGAV & ITGB5 binds ligands containing an RGD motif, notably vitronectin. Growth factors that increase PKC activity, such as VEGF or TGF alpha, promote ITGAV & ITGB5-mediated angiogenesis while alpha V beta 3, which may be expressed in the same cell, responds to FGF-basic and TNF alpha. An inhibitor of both down regulates tumor angiogenesis. During lung inflammation, up regulation of ITGAV & ITGB5 on myofibroblasts or infiltrating lymphocytes may contribute to fibrosis by freeing TGF beta from latency.

Integrin alpha V beta 5 제품 목록

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
RisuteganibALG-1001; AM011; AM-011(Allegro Ophthalmics)Phase 1 ClinicalAllegro Ophthalmics Llc
Diabetic macular oedema; Diabetic Retinopathy; Geographic Atrophy; Macular Degeneration
상세
177Lu-FF-10158177Lu-FF-10158Phase 1 ClinicalFujifilm Holdings Corp
Glioblastoma
상세
NP-011NP-011Phase 1 ClinicalNexell Therapeutics Inc
Myocardial Infarction
상세